Rett Syndrome Clinical Trial
Official title:
The Role of Family Functioning in Adaptation to Being a Caregiver of an Individual With Rett Syndrome
Verified date | January 13, 2016 |
Source | National Institutes of Health Clinical Center (CC) |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Background:
- Rett syndrome (RS) is a panethnic (affecting all ethnicities) neurodevelopmental
(impairment of the growth and development of the brain) disorder affecting primarily
females. RS is characterized by the loss of intellectual functioning, fine and gross
motor skills, and communicative abilities after a period of seemingly normal
development.
- Caregivers of individuals with RS face many psychosocial challenges. The stressors can
be grouped into the following six categories: emotional difficulties, health-related
stressors, uncertainty about their daughter s illness, rejection by their social
environment, lack of available or competent experts, and unfavorable comparison with
healthy children.
- Researchers are making a significant contribution to the adaptation literature with a
focus on family functioning and to the little psychosocial research that exists on
families with RS.
- Researchers hope to narrow down the most important areas on which to focus for
intervention strategies in families with RS.
Objectives:
- To describe family functioning, perceived illness burden, self-efficacy, types of coping
methods, and adaptation in caregivers of individuals with RS to examine the
relationships between these variables and the outcomes of family functioning and
adaptation.
- To examine the extent to which appraisals of being a caregiver of an individual with RS
and methods of coping are associated with family functioning.
- To examine the extent to which appraisals of being a caregiver of an individual with RS,
methods of coping, and family functioning are associated with caregiver adaptation.
Eligibility:
- Eligibility is based on answering yes to the following three questions: Are you 18 years
old or older? Are you the caregiver of a child diagnosed with Rett Syndrome? and Does the
child with Rett Syndrome currently reside in your home with you?
Design:
- Participants in this cross-sectional research design will answer a quantitative survey
that includes some open-ended questions. The cross-sectional study involves a one-time
self-administered questionnaire that takes approximately 20 to 30 minutes to complete.
- The survey will be available in paper and electronic versions and includes demographics
questions, measures of perceived illness burden, parental self-efficacy, coping methods,
family functioning, and adaptation. Participants also will answer open-ended questions
related to the individual s diagnosis.
- Participants may withdraw from the study at any point up until submission of the survey
and may skip any question.
- Participants who experience psychological distress as a result of taking the survey are
advised to contact the researcher. Study coordinators at the various clinics from which
participants will be recruited will be notified of the possibility of adverse events and
instructed to direct any members who experience distress to the appropriate professional
services.
- Participants will receive a small financial compensation for completing the survey.
Status | Completed |
Enrollment | 426 |
Est. completion date | January 13, 2016 |
Est. primary completion date | |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
- INCLUSION CRITERIA: - The study population will consist of men and women ages 18 or older who are the primary caregivers of a child with Rett Syndrome. - The parent may be a biological or adoptive parent or other primary caregiver and the child must reside with the primary caregiver. - Individuals of all ethnic, religious, socioeconomic, and educational backgrounds and from a variety of geographic locations in the United States will be included. EXCLUSION CRITERIA: -Participants must be able to read and write in English, as it is essential for the researchers to be able to understand participants responses. |
Country | Name | City | State |
---|---|---|---|
United States | Kennedy Krieger Institute | Baltimore | Maryland |
United States | University of Alabama | Birmingham | Alabama |
United States | Baylor College of Medicine | Houston | Texas |
Lead Sponsor | Collaborator |
---|---|
National Human Genome Research Institute (NHGRI) |
United States,
Hagberg B. Rett syndrome: clinical peculiarities and biological mysteries. Acta Paediatr. 1995 Sep;84(9):971-6. Review. — View Citation
Lotan M, Ben-Zeev B. Rett syndrome. A review with emphasis on clinical characteristics and intervention. ScientificWorldJournal. 2006 Dec 6;6:1517-41. Review. — View Citation
Weaving LS, Ellaway CJ, Gécz J, Christodoulou J. Rett syndrome: clinical review and genetic update. J Med Genet. 2005 Jan;42(1):1-7. Review. — View Citation
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04988867 -
An Open-Label Study of Trofinetide for the Treatment of Girls Two to Five Years of Age Who Have Rett Syndrome
|
Phase 2/Phase 3 | |
Recruiting |
NCT00069550 -
Independent Studies of Dextromethorphan and of Donepezil Hydrochloride for Rett Syndrome
|
Phase 3 | |
Enrolling by invitation |
NCT06139172 -
Promoting Prosocial Behavior in Syndromic Intellectual and Developmental Disabilities
|
N/A | |
Not yet recruiting |
NCT04041713 -
A Pilot Study of an Antioxidant Cocktail vs. Placebo in the Treatment of Children and Adolescents With Rett Syndrome
|
Phase 2 | |
Not yet recruiting |
NCT04014985 -
Patients With RETT Syndrome
|
N/A | |
Completed |
NCT02705677 -
Biobanking of Rett Syndrome and Related Disorders
|
||
Terminated |
NCT02790034 -
Evaluation of the Efficacy, Safety, and Tolerability of Sarizotan in Rett Syndrome With Respiratory Symptoms
|
Phase 2/Phase 3 | |
Enrolling by invitation |
NCT03655223 -
Early Check: Expanded Screening in Newborns
|
||
Recruiting |
NCT05932589 -
Neurophysiologic Biomarkers in Rett Syndrome
|
||
Recruiting |
NCT04463316 -
GROWing Up With Rare GENEtic Syndromes
|
||
Completed |
NCT04776746 -
Open-Label Extension Study of Trofinetide for Rett Syndrome
|
Phase 3 | |
Completed |
NCT04181723 -
Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome (LAVENDERâ„¢)
|
Phase 3 | |
Enrolling by invitation |
NCT03836300 -
Parent and Infant Inter(X)Action Intervention (PIXI)
|
N/A | |
Completed |
NCT04514549 -
ASSESSING EMERALD AND MC10 BIOSTAMP nPOINT BIOSENSORS FOR RETT SYNDROME
|
||
Terminated |
NCT02562820 -
An Exploratory Trial of Ketamine for the Treatment of Rett Syndrome
|
Phase 1 | |
Completed |
NCT02738281 -
Natural History of Rett Syndrome & Related Disorders
|
||
Completed |
NCT05687214 -
Osteopathic Manipulative Treatment for Constipation in People With Rett Syndrome
|
N/A | |
Recruiting |
NCT06199700 -
Esketamine for the Treatment of Rett Syndrome
|
Early Phase 1 | |
Completed |
NCT03941444 -
ANAVEX2-73 Study in Patients With Rett Syndrome
|
Phase 3 | |
Recruiting |
NCT06346106 -
The Diagnostic Experience of Male Rett Syndrome
|